NVAX Cash & Equivalents
Novavax Inc · Cash & Equivalents
NVAX Cash & Equivalents
Latest reported$240.63Mperiod ending
NVAX FY Cash & Equivalents ($2.50M → $240.63M)
Annual Cash & Equivalents
High-resolution chart · PNG
NVAX cash & equivalents history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Cash & Equivalents (USD) |
|---|---|
| 240,634,000 | |
| 530,230,000 | |
| 568,505,000 | |
| 1,336,883,000 | |
| 1,515,116,000 | |
| 553,398,000 | |
| 78,823,000 | |
| 70,154,000 | |
| 106,307,000 | |
| 144,353,000 | |
| 93,108,000 | |
| 32,335,000 | |
| 119,471,000 | |
| 17,399,000 | |
| 14,104,000 | |
| 8,061,000 | |
| 38,757,000 | |
| 26,938,000 | |
| 4,350,000 | |
| 7,161,000 | |
| 31,893,000 | |
| 17,876,000 | |
| 27,633,000 | |
| 3,005,000 | |
| 20,045,000 | |
| 14,864,000 | |
| 700,000 | |
| 1,000,000 | |
| 3,800,000 | |
| 2,500,000 |